High materiality7/10
Eton Pharmaceuticals price target raised to $78 from $76 at Craig-Hallum
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $78; current price $54.58; upside implied by target upgrade.
- Target uptick to 78; price 54.58.
- Upgrade indicates potential upside.
Key facts
- 01
Target: $78
- 02
Posted price: $54.58
- 03
Analyst firm: Craig-Hallum
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.